Home NDC 17856-1543 Potassium Chloride
Product NDC 17856-1543
11-digit product format 178561543
Labeler code 17856
Product ID 17856-1543_b0d32d53-e93a-466f-9a74-d29a45e1d687
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Potassium Chloride
Dosage form SOLUTION
Route ORAL
Labeler ATLANTIC BIOLOGICALS CORP.
Application NDA206814
Marketing category NDA
Marketing start 2017-02-01
Marketing end 0000-00-00
Substance POTASSIUM CHLORIDE
Active strength 20 meq/15mL
Pharmacologic classes Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 38 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 17856-1543-1 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 17856-1543-1 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 17856-1543-1 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 17856-1543-1 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 17856-1543-1 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 17856-1543-1 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 17856-1543-1 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 17856-1543-1 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 17856-1543-1 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 17856-1543-1 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 17856-1543-1 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 17856-1543-1 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 17856-1543-1 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 17856-1543-1 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 17856-1543-1 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 17856-1543-1 fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 17856-1543-1 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 17856-1543-1 bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 17856-1543-1 8dfbde2a14a4…c9ff85d89658…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N206814-001 POTASSIUM CHLORIDE POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA RLD 2014-12-22 N206814-002 POTASSIUM CHLORIDE POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA RLD, RS 2014-12-22 N206814-003 POKONZA POTASSIUM CHLORIDE 10MEQ/15ML SOLUTION / ORAL RLD 2025-11-25
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Orange Book patents# Current patent rows page 1 of 1 · 2 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N206814-001 12539314 2039-03-07 Drug product 2026-02-04 N206814-002 12539314 2039-03-07 Drug product 2026-02-04
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 91 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N206814-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA RLD 2014-12-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206814-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA RLD, RS 2014-12-22 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206814-003 POKONZA 10MEQ/15ML SOLUTION / ORAL RLD 2025-11-25 84e616aacf4f…2026-08-18 06:07:40 2026-07 N206814-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA RLD 2014-12-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206814-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA RLD, RS 2014-12-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206814-003 POKONZA 10MEQ/15ML SOLUTION / ORAL RLD 2025-11-25 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N206814-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA RLD 2014-12-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206814-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA RLD, RS 2014-12-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206814-003 POKONZA 10MEQ/15ML SOLUTION / ORAL RLD 2025-11-25 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206814-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA RLD 2014-12-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206814-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA RLD, RS 2014-12-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206814-003 POKONZA 10MEQ/15ML SOLUTION / ORAL RLD 2025-11-25 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N206814-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA RLD 2014-12-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206814-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA RLD, RS 2014-12-22 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206814-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA RLD 2014-12-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206814-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA RLD, RS 2014-12-22 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206814-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA RLD 2014-12-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206814-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA RLD, RS 2014-12-22 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206814-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA RLD 2014-12-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206814-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA RLD, RS 2014-12-22 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206814-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA RLD 2014-12-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206814-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA RLD, RS 2014-12-22 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206814-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA RLD 2014-12-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206814-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA RLD, RS 2014-12-22 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206814-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA RLD 2014-12-22 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206814-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA RLD, RS 2014-12-22 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N206814-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA RLD 2014-12-22 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N206814-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA RLD, RS 2014-12-22 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N206814-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA RLD 2014-12-22 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N206814-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA RLD, RS 2014-12-22 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N206814-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA RLD 2014-12-22 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N206814-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA RLD, RS 2014-12-22 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N206814-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA RLD 2014-12-22 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N206814-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA RLD, RS 2014-12-22 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N206814-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA RLD 2014-12-22 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N206814-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA RLD, RS 2014-12-22 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N206814-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA RLD 2014-12-22 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N206814-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA RLD, RS 2014-12-22 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N206814-001 POTASSIUM CHLORIDE 20MEQ/15ML SOLUTION / ORAL AA RLD 2014-12-22 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N206814-002 POTASSIUM CHLORIDE 40MEQ/15ML SOLUTION / ORAL AA RLD, RS 2014-12-22 5d02ea3f76ae…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 86 observed states.
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N206814-001 12539314 2039-03-07 Drug product 2026-02-04 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206814-002 12539314 2039-03-07 Drug product 2026-02-04 84e616aacf4f…2026-08-18 06:07:40 2026-07 N206814-001 12539314 2039-03-07 Drug product 2026-02-04 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206814-002 12539314 2039-03-07 Drug product 2026-02-04 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N206814-001 12539314 2039-03-07 Drug product 2026-02-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206814-002 12539314 2039-03-07 Drug product 2026-02-04 011fe1cb6892…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N206814-001 12539314 2039-03-07 Drug product 2026-02-04 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N206814-002 12539314 2039-03-07 Drug product 2026-02-04 a50c72e98297…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 17856-1543-1 Potassium Chloride 15 mL in 1 CUP, UNIT-DOSE SOLUTION 15 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 17856-1543 POTASSIUM CHLORIDE SOLUTION [ATLANTIC BIOLOGICALS CORP.] 3 Legacy NDC, 1 package rows 20190921_509247a3-1a68-4a36-897d-0c3ade569339.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Status 17856-1543-1 17856154301 15 mL in 1 CUP, UNIT-DOSE 15 ml Historical